About Us

About

A team of award-winning scientists with a mission to empower individuals to make better-informed decisions about their skin health.


The Sequential Skin test is the product of the team’s combined expertise in molecular science, genetics and microbiome research. We use deep molecular analysis and next-generation gene sequencing technology to understand the combined impact of an individual’s genes and their local environment on their skin.

We are brand agnostic and firmly believe in recommending only the products that will yield the best results for each person’s skin. We endeavour to educate every consumer on how active ingredients work to boost skin health, and which compositions are optimal based on each individual’s unique profile.

Through this, we hope to revolutionise how consumers think about and purchase cosmetics, beyond powerful branding and marketing. We want to equip people with the knowledge they need to make the best decisions for their skin.

A team of award-winning scientists with a mission to empower individuals to make better-informed decisions about their skin health.


The Sequential Skin test is the product of the team’s combined expertise in molecular science, genetics and microbiome research. We use deep molecular analysis and next-generation gene sequencing technology to understand the combined impact of an individual’s genes and their local environment on their skin.

We are brand agnostic and firmly believe in recommending only the products that will yield the best results for each person’s skin. We endeavour to educate every consumer on how active ingredients work to boost skin health, and which compositions are optimal based on each individual’s unique profile.

Through this, we hope to revolutionise how consumers think about and purchase cosmetics, beyond powerful branding and marketing. We want to equip people with the knowledge they need to make the best decisions for their skin.
About

Leadership Team

Dr Oliver Worsley

CEO & Co-founder


Oliver is the co-founder and CEO of Sequential Skin. He completed his PhD as a scholar at the Genome Institute of Singapore from 2014-2018, and has won multiple awards including the P&G Young Entrepreneurship Scheme, presented at the Royal Society in London in 2017; and the top prize at the L’Oréal Innovation Runway 2018, with co-founder, Albert Dashi. Oliver is also a published author in the field of microbiome and genetic research, and has also contributed articles in FierceBiotech Research. Prior, Oliver completed his BSc at Edinburgh University, including six months at Leiden University Medical Centre through the Erasmus Programme.

Dr Albert Dashi

Chief Science Officer & Co-founder


Albert is the co-founder and CSO of Sequential Skin. He completed his PhD in molecular genetics, epigenetics and stem cell research at the National University of Singapore (NUS) and the Genome Institute of Singapore in 2019. In 2014, he received the Singapore International Graduate Award from A*STAR for his PhD research and was also awarded the “Young Investigator” award. He also won the “Young Entrepreneur Scheme” award by P&G for his innovative and business driven ideas. Prior moving to Singapore for his doctor program, Albert obtained his Masters in Biomedical Sciences at University of Bern, Switzerland.

Petronille Houdart, PharmD

Skincare Director


Petronille is Sequential Skin’s lead skincare director, focused on translating the latest in skin science to personalised skincare recommendations. She has over a decade in the industry, working with international brands to lead and consult on R&D, creative projects and brand innovation. Petronille also led her own award-winning dermocosmetic brand, Petronille Dermo Cosmetic, that produced customisable products for men and women. Petronille holds an MSc in Cosmetology Sciences and a professional doctorate in pharmacy (specialising in dermo-pharmacy) from Paris Descartes University.

Board of Advisors

Our advisors are world leaders in the skin genetics and the skin microbiome, as well as having experience in commercialising science from the lab bench to the market

Prof. Alexander Lezhava

Senior Group Leader & Associate Director at Genome Institute of Singapore. Expert in the commercial development of medical diagnostics and clinical-grade molecular assays. Doctor of Philosophy (PhD), Microbiology at Hiroshima University.

Prof. Elena Lurie-Luke

Senior R&D, Innovation and Consumer Products executive. Head of Global Life Sciences Open Innovation at Procter & Gamble. Visiting Professor at Durham University UK.

Prof. Niranjan Nagaranjan

Associate Director & Senior Group Leader at Genome Institute of Singapore. Expert in computation biology, in particular the study of microbial communities resident on the human skin. Doctor of Philosophy (PhD), Computer Science at Cornell University.

Michael Matthews, MBA

Strategy Director at Sequential Skin. Highly experienced in Sales and Distribution across APAC & Japan. MBA at Aalto University Executive Education, and currently Founder of Twisted Thinking.

Prof. Tom Dawson

Senior Principal Investigator at Skin Research Institute of Singapore. Over 30 years experience in biotechnology innovations, and expert in the skin and hair microbiome. Doctor of Philosophy (PhD), Pharmacology at University of North Carolina.

Please find a selection of some of the relevant peer-reviewed publications from our advisors below:


Chng, K., Tay, A., Li, C. et al. Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare. Nat Microbiol 1, 16106 (2016).

Wu G, Zhao H, Li C, Rajapakse MP, Wong WC, et al. (2015) Genus-Wide Comparative Genomics of Malassezia Delineates Its Phylogeny, Physiology, and Niche Adaptation on Human Skin. PLOS Genetics 11(11): e1005614.

Tay, A.S. et al (2018). 1039 Skin microbiome profiles of atopic dermatitis patients segregate into two community composition types that are stable before and after therapy. Journal of Investigative Dermatology. 138. S176. 10.1016/j.jid.2018.03.1051.

Tay, Angeline et al (2020). Atopic dermatitis microbiomes stratify into ecologic dermotypes enabling microbial virulence and disease severity. The Journal of allergy and clinical immunology. 10.1016/j.jaci.2020.09.031.